Unicycive Therapeutics, Inc.UNCY

$6.85-0.20 (-2.84%)

NASDAQHealthcare24:00 UTC

Company snapshot

Market Cap

$2B

Small-cap

+2499%

2021 — today

10-Year Price

-85%

2021 — today

52-Week Range

$3.74$8.56

Current $6.85· 65%

Unicycive Therapeutics, Inc. is a U.S.-based biotechnology company dedicated to the creation of innovative treatments for kidney diseases. Its development pipeline includes Renazorb, a therapy for hyperphosphatemia in chronic kidney disease patients, and UNI 494, which is being developed to treat acute kidney injury. Founded in 2016, the firm is headquartered in Los Altos, California.

Valuation in context

P/E ratio

-4.0

N/A

Not meaningful — company is unprofitable

P/B ratio

43.4

Near historic high

Near historic highs — last 10 years

FCF Yield

-1.8%

Near historic high

Near historic highs — last 10 years

Free · No credit card needed

Get alerted when UNCY is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.